Quick Takeaways
- HIGHBRIDGE CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Inmune Bio, Inc. Common Stock, par value $0.001 per share (INMB).
- Disclosed ownership: 5.2%.
- Date of event: 30 Jun 2025.
HIGHBRIDGE CAPITAL MANAGEMENT LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Inmune Bio, Inc. Common Stock, par value $0.001 per share (INMB)
- Filing Manager
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- Reporting Manager
- Highbridge Capital Management, LLC
- Symbol
- INMB
- Shares outstanding
- 27,969,231 shares
- Disclosed Ownership
- 1,454,400 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:05:46 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"HIGHBRIDGE CAPITAL MANAGEMENT LLC disclosed 5.2% ownership in Inmune Bio, Inc. Common Stock, par value $0.001 per share (INMB) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Highbridge Capital Management, LLC | 5.2% | 1,454,400 | 1,454,400 | 0 | /s/ Kirk Rule | Kirk Rule, Executive Director |